Swiss artificial intelligence startup Neural Concept SA said today it has raised $100 million in funding to rethink how products are designed and engineered with computer-aided design software tools.
Computer-aided drug design (CADD) that combines computational chemistry, molecular modeling, and rational drug design with artificial intelligence (AI) and machine learning is rapidly changing the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback